Stocks to Watch: Teladoc, Robert Half and Waste Management
By Dean Seal
Teladoc Health narrowed its loss in the second quarter as revenue climbed to $652.4 million from $592.4 million. For the year, the telemedicine provider now expects between $2.6 billion and $2.68 billion in revenue, raising the low end of its previous guidance, and a per-share loss of $1.25 to $1.60, compared with its prior outlook for a per-share loss of up to $1.70. Shares rise 4.5% to $23.81 in after-hours trading.
Employment agency Robert Half posted earnings of $1 a share for the second quarter, down from $1.60 a share in the same quarter a year ago and below analyst forecasts for $1.13 a share, according to FactSet. Shares fell 11% to $71.50 in aftermarket trading.
Waste Management logged weaker earnings and revenue in the second quarter than analysts had expected and lowered its revenue outlook. Chief Executive Jim Fish says the company is dealing with "persistent inflation in many cost categories, lower-than-anticipated renewable energy prices, and slower-than-planned event-driven volumes." Shares slide 5% to $163.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
July 25, 2023 19:08 ET (23:08 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?